|
|
||||||||
Ann Thorac Surg 2003;75:496-500
© 2003 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery, Kumamoto Central Hospital, Kumamoto-shi, Japan
b Department of Department of Cardiothoracic Surgery, Saga Medical School, Saga-shi, Japan
Accepted for publication August 29, 2002.
* Address reprint requests to Dr Nakayama, Nagasaki Kôseikai Hospital, 1-3-12 Hayama, Nagasaki-shi 852-8053, Japan.
e-mail: kita4f{at}mocha.ocn.ne.jp
| Abstract |
|---|
|
|
|---|
METHODS: This retrospective study focuses on 117 consecutive coronary artery bypass grafting patients with renal insufficiency, but who did not require dialysis (group B: preoperative serum creatinine level
1.5 mg/dL). For comparison purposes, patients on maintenance dialysis (group C: 84 patients) and patients with normal renal function (group A: 794 patients; preoperative serum creatinine level < 1.0 mg/dL) were selected.
RESULTS: Hospital mortality was 11% (13 of 117) in group B, 5.9% (5 of 84) in group C, and 1.6% (13 of 794) in group A, and between groups A and B, p < 0.0001, and between groups B and C, p = 0.24. Actuarial survival rates at 10 years, including all deaths, were 87%, 32%, and 29% in groups A, B and C, respectively, and between groups A and B, p < 0.009 and between groups B and C, p = 0.63. In 23 patients in group B, the bilateral internal thoracic artery was used. No cardiac deaths were observed in these patients during the mean follow-up time of 42 months (range, 1 to 128 months). Cox model analysis revealed nonuse of arterial grafting (p = 0.03; Hazards ratio 1.7) to be a statistically significant factor, and renal insufficiency (p < 0.0001; Hazards ratio 3.3) and maintenance dialysis (p < 0.0001; Hazards ratio 5.6) to be major independent risk factors for actuarial survival.
CONCLUSIONS: Renal insufficiency was shown to be an independent risk factor for poor prognosis after coronary artery bypass grafting. However, aggressive use of arterial grafts, especially the internal thoracic artery, is recommended to improve late outcomes.
| Introduction |
|---|
|
|
|---|
| Material and methods |
|---|
|
|
|---|
1.5 mg/dL). For comparison purposes, CABG patients on maintenance dialysis (group C: 84 patients; 5.8%) and CABG patients with normal renal function (group A: preoperative serum creatinine level < 1.0 mg/dL; 794 patients; 55%) were selected. The four hun dred fifty-five patients (31%) with preoperative serum creatinine levels above 1.0 mg/dL but below 1.5 mg/dL were excluded from this study (Table 1).
|
Statistical analysis
The
2 test was used for the nonparametric variables, and the unpaired t test for continuous variables; a p value of less than 0.05 was regarded as statistically significant. Long-term survival rates were calculated using the Kaplan-Meier method, and statistical significance was analyzed using the Cox-Mantel test. Sudden death and death for unknown reasons was categorized as cardiac death. The Cox proportional hazards model was used to analyze the independent risk factors influencing the outcome of all-cause mortality. All data are presented as mean ± standard deviation unless otherwise stated. The data were analyzed using the StatView J5.0 statistical software package (Abacus Concepts, Inc, Berkeley, CA).
| Results |
|---|
|
|
|---|
Table 2 summarizes the preoperative conditions and surgical procedures in groups A, B, and C. A comparison between groups A and B revealed numerous measure-ments to be statistically significant: mean age, diabetes mellitus, atherosclerotic obstructive disease, New York Heart Association functional class, left main trunk disease, mean left ventricular ejection fraction, emergent operation, CABG using saphenous vein grafting (SVG) only, and CABG using two or more arterial grafts. Between groups B and C the identified mean age and CABG using SVG only proved to be significantly different.
|
Long-term results
The mean follow-up time was 43 months (range, 1 to 128 months), 43 months (1 to 125 months) and 40 months (1 to 122 months) in groups A, B, and C, respectively. Actuarial survival rates at 10 years including all deaths were 87%, 32%, and 29% in groups A, B, and C. A significant difference was observed between groups A and B (p < 0.009), but not between groups B and C (p = 0.63) (Fig 1).
Actuarial survival rates estimated by cardiac deaths were 95%, 74%, and 88% in groups A, B, and C. A significant difference was observed between groups A and B (p = 0.0013) but not between groups B and C (p = 0.52) (Fig 2).
The cardiac-related event-free rate was 77%, 71%, and 78% in groups A, B, and C without significant difference (Fig 3).
|
|
|
|
In group B, 19 patients were placed on maintenance hemodialysis because of progressive loss of renal function after CABG. The 117 patients in group B were divided into two groups: 69 patients showed preoperative serum creatinine levels of 1.5 mg/dL to 2.0 mg/dL and were designated as having mild renal dysfunction; 48 patients with creatinine levels exceeding 2.0 mg/dL were designated as having severe renal dysfunction. Fifteen patients (31%) of the severe renal dysfunction group were required to go on hemodialysis after CABG. Figure 4 illustrates the hemodialysis induction-free rate. The rate at 10 years was 89% and 33% in patients with mild and severe renal dysfunction, respectively, with a statistical significance of p less than 0.009.
|
70 years), gender, hypertension, diabetes mellitus, prior history of cerebral infarction, 3-vessel disease, New York Heart Association functional class III, left ventricular dysfunction (left ventricular ejection fraction < 40%), emergent operation, nonuse of arterial grafting, renal dysfunction (group B only), and maintenance dialysis (group C only) (Table 4).
Age, prior history of cerebral infarction, left ventricular dysfunction (left ventricular ejection fraction < 40%), and nonuse of arterial grafting were statistically significant, particularly with respect to renal dysfunction (group B) and maintenance dialysis (group C).
|
| Comment |
|---|
|
|
|---|
In the case of renal insufficiency, tolerance of cardiopulmonary bypass (CPB) surgical procedure may be reduced because of the patients inability to cope with massive fluid shifts in different body compartments induced by CPB. In addition, because of the associated comorbid complications caused by advanced arteriosclerosis, the operative mortality of patients with renal failure is markedly higher than in patients with normal renal function. Browner and Mangano [10] initially suggested impaired renal function to be an important predictor of postoperative mortality. OConnor and colleagues [11], after an analysis of more than 3,000 patients at five centers, found that preexisting renal failure (magnitude not otherwise defined) significantly increased in-hospital mortality after CABG (odds ratio, 5.2; 95% confidence intervals, 2.5 to 11.1). Shroyer and colleagues [12] analyzed more than 135,000 CABG patient records from the Society of Thoracic Surgeons National Adult Cardiac Database and found that a preoperative creatinine concentration of 2.0 mg/dL or above was significantly associated with increased rates of postoperative death, with an odds ratio of 2.01. Anderson and colleagues [8] reported that patients with a serum creatinine level of 1.5 to 3.0 mg/dL had a higher 30-day mortality (7% vs 3%; p < 0.001) than did patients with a base line serum creatinine of less than 1.5 mg/dL. Also in our study, the operative mortality of group B (Cr
1.5 mg/dL) was significantly higher than that of group A (Cr < 1.0 mg/dL; p < 0.0001).
Both the short-term and long-term results of group B were clearly worse than those of group A, and similar to those of dialysis patients (group C). The causes of late death were mainly infection, cancer, and cerebrovascular accidents. In dialysis patients, it is clear that several factors may have contributed to the high mortality rate. Reduced resistance to infection is attributed to decreased leukocyte chemotaxis combined with leukopenia [13]. Accelerated arteriosclerosis [14], often in vessels in the neck, is manifested as cerebrovascular complications, and the susceptibility of dialysis patients to cancer is well known [15]. In patients with renal insufficiency (group B), it is assumed that high late mortality caused by noncardiac death is attributable to the same causes.
As demonstrated in Table 2, compared with group A, many patients in group B suffered unfavorable preoperative and intraoperative conditions that affected both surgical and long-term results. However, the Cox model showed preoperative renal insufficiency (group B) per se to be an independent risk factor for actuarial survival rate (Table 3).
Actuarial survival rate estimated by cardiac death in group B was also worse than that seen in group A. Nine cardiac late deaths were observed in group B and 6 were caused by congestive heart failure. These results are not surprising because group B included many patients with poor preoperative left ventricular function and poor renal prognosis. Eight of the 9 patients who had cardiac late death were bypassed using only SVG. CABG using only SVG was also an independent risk factor for actuarial survival rate (Table 3).
In group B, we used bilateral ITA in 23 patients. Although no significant difference was observed in cardiac related death-free rate at 10 years compared with patients with single (left) ITA (100% vs 88%; p = 0.19), cardiac death appeared to be prevented by the use of bilateral ITA. In addition, compared with patients using SVG only, use of bilateral ITA statistically significantly improved the cardiac related death-free rate (100% vs 58%; p = 0.04), but there was no difference between patients with single (left) ITA (88% vs 58%; p = 0.22).
These facts suggest that arterial grafting leads to improved outcomes after CABG in patients with renal insufficiency. Buxton and colleagues [16] similarly reported that use of the bilateral ITA may result in better outcome after CABG compared with single ITA grafting. In this report the difference in results between bilateral ITA and single ITA grafting was more clearly manifested in patients with less favorable preoperative conditions, specifically poor left ventricular function, diabetes mellitus, peripheral vascular disease, and carotid disease. Although Buxton and colleagues [16] did not discuss renal dysfunction, their results support our view.
Because of the low hemodialysis induction-free rate in patients with renal insufficiency (especially in patients with a preoperative creatinine level of
2.0 mg/dL), as mentioned above, the radial and gastroepiploic arteries should be preserved to assist future blood access or peritoneal dialysis. Use of the ITA is thus recommended. In the past, poor wound healing and increased bleeding resulting from the use of the ITA was assumed to rule out the choice of this technique in renal dialysis patients [17]. However, we have previously reported on the safety of the use of bilateral ITAs [18] and the usefulness of multiarterial grafts [6] in dialysis patients, and we believe that the same principle applies to patients such as those in group B who have renal insufficiency but are not undergoing dialysis.
In conclusion, patients with renal insufficiency (group B) had a poor prognosis after CABG because of the high rates of cardiac and noncardiac death. As cardiac surgeons, because it is difficult to prevent noncardiac deaths, the focus of our efforts therefore is on reducing cardiac deaths. Aggressive use of arterial grafting, especially the ITA, is recommended to improve late outcome.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. H.M. van Straten, M. A. Soliman Hamad, A. A.J. van Zundert, E. J. Martens, J. P.A.M. Schonberger, and A. M. de Wolf Preoperative renal function as a predictor of survival after coronary artery bypass grafting: Comparison with a matched general population J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 971 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Horai, T. Fukui, M. Tabata, and S. Takanashi Early and mid-term results of off-pump coronary artery bypass grafting in patients with end stage renal disease: surgical outcomes after achievement of complete revascularization Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 218 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Simon, R. Luciani, F. Capuano, A. Miceli, A. Roscitano, E. Tonelli, and R. Sinatra Mild and moderate renal dysfunction: impact on short-term outcome Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 286 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Capuano, R. Bianchini, M. Goracci, A. Roscitano, R. Luciani, C. Simon, L. Giusti, and R. Sinatra Intraoperative Veno-Arterial Hemofiltration During Miniaturized Extracorporeal Bypass Ann. Thorac. Surg., June 1, 2007; 83(6): 2215 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Holzmann, N. Hammar, S. Ahnve, T. Nordqvist, K. Pehrsson, and T. Ivert Renal insufficiency and long-term mortality and incidence of myocardial infarction in patients undergoing coronary artery bypass grafting Eur. Heart J., April 1, 2007; 28(7): 865 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Parikh, S. G. Coca, G. L. Smith, V. Vaccarino, and H. M. Krumholz Impact of Chronic Kidney Disease on Health-Related Quality-of-Life Improvement After Coronary Artery Bypass Surgery. Arch Intern Med, October 9, 2006; 166(18): 2014 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Hillis, B. L. Croal, K. G. Buchan, H. El-Shafei, G. Gibson, R. R. Jeffrey, C. G.M. Millar, G. J. Prescott, and B. H. Cuthbertson Renal Function and Outcome From Coronary Artery Bypass Grafting: Impact on Mortality After a 2.3-Year Follow-Up Circulation, February 28, 2006; 113(8): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schachner, A. Zimmer, G. Nagele, H. Hangler, G. Laufer, and J. Bonatti The influence of ascending aortic atherosclerosis on the long-term survival after CABG Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 558 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Holzmann, S. Ahnve, N. Hammar, L. Jorgensen, K. Klerdal, K. Pehrsson, and T. Ivert Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 746 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Massad, J. Kpodonu, J. Lee, J. Espat, S. Gandhi, A. Tevar, and A. S. Geha Outcome of Coronary Artery Bypass Operations in Patients With Renal Insufficiency With and Without Renal Transplantation Chest, August 1, 2005; 128(2): 855 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Witczak, A. Hartmann, and J. L. Svennevig Multiple Risk Assessment of Cardiovascular Surgery in Chronic Renal Failure Patients Ann. Thorac. Surg., April 1, 2005; 79(4): 1297 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Sackner-Bernstein, H. A. Skopicki, and K. D. Aaronson Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure Circulation, March 29, 2005; 111(12): 1487 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M.A. van de Wal, B. L. van Brussel, A. A. Voors, T. D.J. Smilde, J. C. Kelder, H. A. van Swieten, W. H. van Gilst, D. J. van Veldhuisen, and H.W. T. Plokker Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tabata, S. Takanashi, T. Fukui, T. Horai, T. Uchimuro, K. Kitabayashi, and Y. Hosoda Off-Pump Coronary Artery Bypass Grafting in Patients With Renal Dysfunction Ann. Thorac. Surg., December 1, 2004; 78(6): 2044 - 2049. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marenzi, G. Lauri, E. Assanelli, J. Campodonico, M. De Metrio, I. Marana, M. Grazi, F. Veglia, and A. L. Bartorelli Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1780 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gupta, Y. Birnbaum, and B. F. Uretsky The renal patient with coronary artery disease: Current concepts and dilemmas J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1343 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gibson, D. S. Pinto, S. A. Murphy, D. A. Morrow, H.-P. Hobbach, S. D. Wiviott, R. P. Giugliano, C. P. Cannon, E. M. Antman, E. Braunwald, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1535 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Ngaage Off-pump coronary artery bypass grafting: the myth, the logic and the science Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 557 - 570. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |